231 related articles for article (PubMed ID: 25911189)
1. Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.
Das A; Salloum FN; Filippone SM; Durrant DE; Rokosh G; Bolli R; Kukreja RC
Basic Res Cardiol; 2015 May; 110(3):31. PubMed ID: 25911189
[TBL] [Abstract][Full Text] [Related]
2. STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice.
Samidurai A; Roh SK; Prakash M; Durrant D; Salloum FN; Kukreja RC; Das A
Cardiovasc Res; 2020 Nov; 116(13):2103-2115. PubMed ID: 31738412
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway.
Das A; Salloum FN; Durrant D; Ockaili R; Kukreja RC
J Mol Cell Cardiol; 2012 Dec; 53(6):858-69. PubMed ID: 22999860
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.
Samidurai A; Salloum FN; Durrant D; Chernova OB; Kukreja RC; Das A
Br J Pharmacol; 2017 Dec; 174(24):4771-4784. PubMed ID: 28967097
[TBL] [Abstract][Full Text] [Related]
6. Lin28a protects against cardiac ischaemia/reperfusion injury in diabetic mice through the insulin-PI3K-mTOR pathway.
Zhang M; Sun D; Li S; Pan X; Zhang X; Zhu D; Li C; Zhang R; Gao E; Wang H
J Cell Mol Med; 2015 Jun; 19(6):1174-82. PubMed ID: 25688987
[TBL] [Abstract][Full Text] [Related]
7. Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK.
Filippone SM; Samidurai A; Roh SK; Cain CK; He J; Salloum FN; Kukreja RC; Das A
Oxid Med Cell Longev; 2017; 2017():4619720. PubMed ID: 28373901
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart.
Ma LL; Ma X; Kong FJ; Guo JJ; Shi HT; Zhu JB; Zou YZ; Ge JB
J Cell Mol Med; 2018 Mar; 22(3):1708-1719. PubMed ID: 29314656
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion.
Fuglesteg BN; Suleman N; Tiron C; Kanhema T; Lacerda L; Andreasen TV; Sack MN; Jonassen AK; Mjøs OD; Opie LH; Lecour S
Basic Res Cardiol; 2008 Sep; 103(5):444-53. PubMed ID: 18500485
[TBL] [Abstract][Full Text] [Related]
10. Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion.
Aoyagi T; Higa JK; Aoyagi H; Yorichika N; Shimada BK; Matsui T
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1530-9. PubMed ID: 25888508
[TBL] [Abstract][Full Text] [Related]
11. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
[TBL] [Abstract][Full Text] [Related]
12. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.
Das A; Durrant D; Koka S; Salloum FN; Xi L; Kukreja RC
J Biol Chem; 2014 Feb; 289(7):4145-60. PubMed ID: 24371138
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways.
Xue R; Lei S; Xia ZY; Wu Y; Meng Q; Zhan L; Su W; Liu H; Xu J; Liu Z; Zhou B; Xia Z
Clin Sci (Lond); 2016 Mar; 130(5):377-92. PubMed ID: 26666444
[TBL] [Abstract][Full Text] [Related]
15. Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury.
Qian J; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y
Cardiovasc Drugs Ther; 2016 Apr; 30(2):129-41. PubMed ID: 26861490
[TBL] [Abstract][Full Text] [Related]
16. Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury.
Si R; Tao L; Zhang HF; Yu QJ; Zhang R; Lv AL; Zhou N; Cao F; Guo WY; Ren J; Wang HC; Gao F
J Mol Cell Cardiol; 2011 Jan; 50(1):16-24. PubMed ID: 20801129
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
Obana M; Miyamoto K; Murasawa S; Iwakura T; Hayama A; Yamashita T; Shiragaki M; Kumagai S; Miyawaki A; Takewaki K; Matsumiya G; Maeda M; Yoshiyama M; Nakayama H; Fujio Y
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H569-77. PubMed ID: 22707562
[TBL] [Abstract][Full Text] [Related]
19. Cardiac mTOR protects the heart against ischemia-reperfusion injury.
Aoyagi T; Kusakari Y; Xiao CY; Inouye BT; Takahashi M; Scherrer-Crosbie M; Rosenzweig A; Hara K; Matsui T
Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H75-85. PubMed ID: 22561297
[TBL] [Abstract][Full Text] [Related]
20. SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury.
Huang C; Gu H; Zhang W; Manukyan MC; Shou W; Wang M
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1496-505. PubMed ID: 21821779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
